Markets:

Overview

News

Currencies

International

Treasuries

Ovid Therapeutics Inc. - Common Stock (NQ:OVID)

1.470 -0.050 (-3.29%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ovid Therapeutics Inc. - Common Stock

< Previous 1 2 3 Next >

AAN Stock Alert: The Aaron’s Company Pops 33% on Take-Private Deal ↗

June 17, 2024

The Aaron's Company stock is up on Monday after it announced a take-private deal that values AAN shares at $10.10 each.

Via InvestorPlace

Why Is Ovid Therapeutics (OVID) Stock Down 69% Today? ↗

June 17, 2024

Ovid Therapeutics stock is down on Monday with heavy trading of OVID shares after the company reported a failed Phase3 clinical trial.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 17, 2024

Via Benzinga

Crude Oil Rises 1%; Mustang Bio Shares Spike Higher ↗

June 17, 2024

Via Benzinga

US Stocks Mixed; Dow Tumbles Over 100 Points ↗

June 17, 2024

Via Benzinga

Topics Stocks

Cracking The Code: Understanding Analyst Reviews For Ovid Therapeutics ↗

May 07, 2024

Via Benzinga

Recap: Ovid Therapeutics Q4 Earnings ↗

March 08, 2024

Via Benzinga

Ovid Therapeutics Earnings Perspective: Return On Capital Employed ↗

May 22, 2023

Via Benzinga

Ovid Therapeutics: Q1 Earnings Insights ↗

May 05, 2023

Via Benzinga

What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail? ↗

June 17, 2024

Takeda Pharmaceutical reveals Phase 3 study data for Soticlestat (TAK-935) in treating Dravet and Lennox-Gastaut syndromes. In 2021, Ovid Therapeutics out licensed the drug.

Via Benzinga

Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

June 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 17, 2024

Via Benzinga

3 Sorry Penny Stocks to Sell in May While You Still Can ↗

May 28, 2024

Steer clear of these three penny stocks to sell that are plagued by financial instability and mounting losses.

Via InvestorPlace

Looking Into Ovid Therapeutics's Return On Capital Employed ↗

March 15, 2023

Via Benzinga

Ovid Therapeutics: Q1 Earnings Insights ↗

May 10, 2022

Ovid Therapeutics (NASDAQ:OVID) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024 ↗

May 20, 2024

Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments.

Via InvestorPlace

OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

OVID stock results show that Ovid Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 24, 2024

Via Benzinga

Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

March 21, 2024

The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

3 Very Promising Penny Stocks That Are Flying Under the Radar ↗

August 15, 2023

Although the very concept of penny stocks to buy screams risk, these ideas just might be intriguing enough for speculators.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗

June 14, 2023

Via Benzinga

The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech ↗

April 14, 2023

One executive called this the most "damaging" decision in five decades.

Via Investor's Business Daily

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗

April 12, 2023

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...

Via Benzinga

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗

April 11, 2023

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...

Via Benzinga

Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension ↗

April 11, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

May 26, 2022

On Thursday, 94 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 23, 2022

On Monday, 149 companies reached new 52-week lows.

Via Benzinga

3 Biotech Stocks Under $10 to Add to Your Buy List ↗

April 26, 2022

These biotech stocks to buy are all profitable, which is important for investors looking to reduce their investment risk.

Via InvestorPlace

Overview Of Value Stocks In The Healthcare Sector ↗

April 11, 2022

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

February 21, 2022

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ovid Therapeutics Inc. - Common Stock (NQ:OVID)

Headline News about Ovid Therapeutics Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today